-
1
-
-
84874824543
-
Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
-
23359661 10.2967/jnumed.113.120618 1:CAS:528:DC%2BC3sXltV2ks7g%3D
-
Johnson KA, Minoshima S, Bohnen NI, Donohoe KJ, Foster NL, Herscovitch P, et al. Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. J Nucl Med. 2013;54:476-90.
-
(2013)
J Nucl Med
, vol.54
, pp. 476-490
-
-
Johnson, K.A.1
Minoshima, S.2
Bohnen, N.I.3
Donohoe, K.J.4
Foster, N.L.5
Herscovitch, P.6
-
2
-
-
10744232413
-
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
-
14991808 10.1002/ana.20009 1:CAS:528:DC%2BD2cXisFKntb8%3D
-
Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306-19.
-
(2004)
Ann Neurol
, vol.55
, pp. 306-319
-
-
Klunk, W.E.1
Engler, H.2
Nordberg, A.3
Wang, Y.4
Blomqvist, G.5
Holt, D.P.6
-
3
-
-
33750975078
-
Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease
-
16971697 10.1212/01.wnl.0000240117.55680.0a 1:STN:280: DC%2BD28nmslagsQ%3D%3D
-
Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, et al. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology. 2006;67:1575-80.
-
(2006)
Neurology
, vol.67
, pp. 1575-1580
-
-
Kemppainen, N.M.1
Aalto, S.2
Wilson, I.A.3
Någren, K.4
Helin, S.5
Brück, A.6
-
4
-
-
33847062118
-
Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study
-
17065593 10.1212/01.wnl.0000244749.20056.d4 1:STN:280: DC%2BD2s%2FpsFymsA%3D%3D
-
Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology. 2007;68:501-8.
-
(2007)
Neurology
, vol.68
, pp. 501-508
-
-
Edison, P.1
Archer, H.A.2
Hinz, R.3
Hammers, A.4
Pavese, N.5
Tai, Y.F.6
-
5
-
-
56749185181
-
Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
-
18653550 10.1136/jnnp.2007.127878 1:STN:280:DC%2BD1cjktFSgsg%3D%3D
-
Edison P, Rowe CC, Rinne JO, Ng S, Ahmed I, Kemppainen N, et al. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry. 2008;79:1331-8.
-
(2008)
J Neurol Neurosurg Psychiatry
, vol.79
, pp. 1331-1338
-
-
Edison, P.1
Rowe, C.C.2
Rinne, J.O.3
Ng, S.4
Ahmed, I.5
Kemppainen, N.6
-
6
-
-
54049100454
-
Imaging amyloid deposition in Lewy body diseases
-
18794492 10.1212/01.wnl.0000326146.60732.d6 1:STN:280: DC%2BD1cngs1amtw%3D%3D
-
Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, et al. Imaging amyloid deposition in Lewy body diseases. Neurology. 2008;71:903-10.
-
(2008)
Neurology
, vol.71
, pp. 903-910
-
-
Gomperts, S.N.1
Rentz, D.M.2
Moran, E.3
Becker, J.A.4
Locascio, J.J.5
Klunk, W.E.6
-
7
-
-
77950535797
-
Relationship between atrophy and beta-amyloid deposition in Alzheimer disease
-
20373343
-
Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, et al. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol. 2010;67:317-24.
-
(2010)
Ann Neurol
, vol.67
, pp. 317-324
-
-
Chételat, G.1
Villemagne, V.L.2
Bourgeat, P.3
Pike, K.E.4
Jones, G.5
Ames, D.6
-
8
-
-
84856235427
-
In vivo imaging of astrocytosis in Alzheimer's disease: An 11C-L-deuteriodeprenyl and PIB PET study
-
21853308 10.1007/s00259-011-1895-9
-
Santillo AF, Gambini JP, Lannfelt L, Långström B, Ulla-Marja L, Kilander L, et al. In vivo imaging of astrocytosis in Alzheimer's disease: an 11C-L-deuteriodeprenyl and PIB PET study. Eur J Nucl Med Mol Imaging. 2011;38:2202-8.
-
(2011)
Eur J Nucl Med Mol Imaging
, vol.38
, pp. 2202-2208
-
-
Santillo, A.F.1
Gambini, J.P.2
Lannfelt, L.3
Långström, B.4
Ulla-Marja, L.5
Kilander, L.6
-
9
-
-
84873655842
-
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
-
22961445 10.1007/s00259-012-2237-2 1:CAS:528:DC%2BC38XhslyjtrvP
-
Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, et al. A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2013;40:104-14.
-
(2013)
Eur J Nucl Med Mol Imaging
, vol.40
, pp. 104-114
-
-
Nordberg, A.1
Carter, S.F.2
Rinne, J.3
Drzezga, A.4
Brooks, D.J.5
Vandenberghe, R.6
-
10
-
-
70350537003
-
Test-retest variability of quantitative [11C]PIB studies in Alzheimer's disease
-
19384547 10.1007/s00259-009-1129-6
-
Tolboom N, Yaqub M, Boellaard R, Luurtsema G, Windhorst AD, Scheltens P, et al. Test-retest variability of quantitative [11C]PIB studies in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2009;36:1629-38.
-
(2009)
Eur J Nucl Med Mol Imaging
, vol.36
, pp. 1629-1638
-
-
Tolboom, N.1
Yaqub, M.2
Boellaard, R.3
Luurtsema, G.4
Windhorst, A.D.5
Scheltens, P.6
-
11
-
-
36849088537
-
In vivo amyloid imaging with PET in frontotemporal dementia
-
17846768 10.1007/s00259-007-0523-1
-
Engler H, Santillo AF, Wang SX, Lindau M, Savitcheva I, Nordberg A, et al. In vivo amyloid imaging with PET in frontotemporal dementia. Eur J Nucl Med Mol Imaging. 2008;35:100-6.
-
(2008)
Eur J Nucl Med Mol Imaging
, vol.35
, pp. 100-106
-
-
Engler, H.1
Santillo, A.F.2
Wang, S.X.3
Lindau, M.4
Savitcheva, I.5
Nordberg, A.6
-
12
-
-
33947198109
-
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: A case report
-
17353389 10.1001/archneur.64.3.431
-
Bacskai BJ, Frosch MP, Freeman SH, Raymond SB, Augustinack JC, Johnson KA, et al. Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol. 2007;64:431-4.
-
(2007)
Arch Neurol
, vol.64
, pp. 431-434
-
-
Bacskai, B.J.1
Frosch, M.P.2
Freeman, S.H.3
Raymond, S.B.4
Augustinack, J.C.5
Johnson, K.A.6
-
13
-
-
43849083580
-
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
-
18339640 10.1093/brain/awn016
-
Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain. 2008;131:1630-45.
-
(2008)
Brain
, vol.131
, pp. 1630-1645
-
-
Ikonomovic, M.D.1
Klunk, W.E.2
Abrahamson, E.E.3
Mathis, C.A.4
Price, J.C.5
Tsopelas, N.D.6
-
14
-
-
84857843988
-
Early AD pathology in a [C-11]PiB-negative case: A PiB-amyloid imaging, biochemical, and immunohistochemical study
-
22271153 10.1007/s00401-012-0943-2 1:CAS:528:DC%2BC38Xisl2ktbk%3D
-
Ikonomovic MD, Abrahamson EE, Price JC, Hamilton RL, Mathis CA, Paljug WR, et al. Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study. Acta Neuropathol. 2012;123:433-47.
-
(2012)
Acta Neuropathol.
, vol.123
, pp. 433-447
-
-
Ikonomovic, M.D.1
Abrahamson, E.E.2
Price, J.C.3
Hamilton, R.L.4
Mathis, C.A.5
Paljug, W.R.6
-
15
-
-
38149081191
-
Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: Proof of mechanism
-
18191617 10.1016/S1474-4422(08)70001-2 1:CAS:528:DC%2BD1cXis1WmsLw%3D
-
Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O'Keefe G, et al. Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol. 2008;7:129-35.
-
(2008)
Lancet Neurol
, vol.7
, pp. 129-135
-
-
Rowe, C.C.1
Ackerman, U.2
Browne, W.3
Mulligan, R.4
Pike, K.L.5
O'Keefe, G.6
-
16
-
-
66149104129
-
Whole-body biodistribution and radiation dosimetry of 18F-GE067: A radioligand for in vivo brain amyloid imaging
-
19372469 10.2967/jnumed.108.060756 1:CAS:528:DC%2BD1MXmtV2hsrk%3D
-
Koole M, Lewis DM, Buckley C, Nelissen N, Vandenbulcke M, Brooks DJ, et al. Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging. J Nucl Med. 2009;50:818-22.
-
(2009)
J Nucl Med
, vol.50
, pp. 818-822
-
-
Koole, M.1
Lewis, D.M.2
Buckley, C.3
Nelissen, N.4
Vandenbulcke, M.5
Brooks, D.J.6
-
17
-
-
77953937194
-
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir F 18)
-
20501908 10.2967/jnumed.109.069088 1:CAS:528:DC%2BC3cXosl2ksb4%3D
-
Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, et al. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir F 18). J Nucl Med. 2010;51:913-20.
-
(2010)
J Nucl Med
, vol.51
, pp. 913-920
-
-
Wong, D.F.1
Rosenberg, P.B.2
Zhou, Y.3
Kumar, A.4
Raymont, V.5
Ravert, H.T.6
-
18
-
-
78751546481
-
Use of florbetapir-PET for imaging beta-amyloid pathology
-
21245183 10.1001/jama.2010.2008 1:CAS:528:DC%2BC3MXhtVGrurw%3D
-
Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA. 2011;305:275-83.
-
(2011)
JAMA
, vol.305
, pp. 275-283
-
-
Clark, C.M.1
Schneider, J.A.2
Bedell, B.J.3
Beach, T.G.4
Bilker, W.B.5
Mintun, M.A.6
-
19
-
-
79954748692
-
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: A multicentre phase 2 diagnostic study
-
21481640 10.1016/S1474-4422(11)70077-1 1:CAS:528:DC%2BC3MXlt1Sls7c%3D
-
Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, et al. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol. 2011;10:424-35.
-
(2011)
Lancet Neurol
, vol.10
, pp. 424-435
-
-
Barthel, H.1
Gertz, H.J.2
Dresel, S.3
Peters, O.4
Bartenstein, P.5
Buerger, K.6
-
20
-
-
84858607421
-
Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand
-
22323782 10.2967/jnumed.111.094029
-
Cselényi Z, Jönhagen ME, Forsberg A, Halldin C, Julin P, Schou M, et al. Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand. J Nucl Med. 2012;53:415-24.
-
(2012)
J Nucl Med
, vol.53
, pp. 415-424
-
-
Cselényi, Z.1
Jönhagen, M.E.2
Forsberg, A.3
Halldin, C.4
Julin, P.5
Schou, M.6
-
21
-
-
84863869296
-
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: A prospective cohort study
-
22749065 10.1016/S1474-4422(12)70142-4 1:CAS:528:DC%2BC38XhtV2gtb3E
-
Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: A prospective cohort study. Lancet Neurol. 2012;11:669-78.
-
(2012)
Lancet Neurol
, vol.11
, pp. 669-678
-
-
Clark, C.M.1
Pontecorvo, M.J.2
Beach, T.G.3
Bedell, B.J.4
Coleman, R.E.5
Doraiswamy, P.M.6
-
22
-
-
84874222233
-
[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: Pooled analysis of four studies
-
23053137 10.1007/s00401-012-1051-z 1:CAS:528:DC%2BC38XhslKls7zI
-
Rinne JO, Wong DF, Wolk DA, Leinonen V, Arnold SE, Buckley C, et al. [18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies. Acta Neuropathol. 2012;124:833-45.
-
(2012)
Acta Neuropathol
, vol.124
, pp. 833-845
-
-
Rinne, J.O.1
Wong, D.F.2
Wolk, D.A.3
Leinonen, V.4
Arnold, S.E.5
Buckley, C.6
-
23
-
-
70349582720
-
Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study
-
19587325 10.1212/WNL.0b013e3181b23564 1:CAS:528:DC%2BD1MXhtVKrsbvF
-
Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, Någren K, et al. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology. 2009;73:754-60.
-
(2009)
Neurology
, vol.73
, pp. 754-760
-
-
Okello, A.1
Koivunen, J.2
Edison, P.3
Archer, H.A.4
Turkheimer, F.E.5
Någren, K.6
-
24
-
-
79953177902
-
Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study
-
21325653 10.1212/WNL.0b013e318212015e 1:STN:280:DC%2BC3M3ot1Klsg%3D%3D
-
Koivunen J, Scheinin N, Virta JR, Aalto S, Vahlberg T, Någren K, et al. Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study. Neurology. 2011;76:1085-90.
-
(2011)
Neurology
, vol.76
, pp. 1085-1090
-
-
Koivunen, J.1
Scheinin, N.2
Virta, J.R.3
Aalto, S.4
Vahlberg, T.5
Någren, K.6
-
25
-
-
0035168927
-
Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease
-
11816784 10.1385/JMN:17:2:101 1:CAS:528:DC%2BD3MXosVKitrg%3D
-
Morris JC, Price JL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci. 2001;17:101-18.
-
(2001)
J Mol Neurosci
, vol.17
, pp. 101-118
-
-
Morris, J.C.1
Price, J.L.2
-
26
-
-
71849110016
-
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2
-
19838705 10.1007/s00259-009-1264-0
-
Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Någren K, et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009;36:2103-10.
-
(2009)
Eur J Nucl Med Mol Imaging
, vol.36
, pp. 2103-2110
-
-
Varrone, A.1
Asenbaum, S.2
Vander Borght, T.3
Booij, J.4
Nobili, F.5
Någren, K.6
-
27
-
-
71849102802
-
EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2
-
19838703 10.1007/s00259-009-1266-y 1:CAS:528:DC%2BD1MXhsVCisb3L
-
Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Någren K, et al. EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. Eur J Nucl Med Mol Imaging. 2009;36:2093-102.
-
(2009)
Eur J Nucl Med Mol Imaging
, vol.36
, pp. 2093-2102
-
-
Kapucu, O.L.1
Nobili, F.2
Varrone, A.3
Booij, J.4
Vander Borght, T.5
Någren, K.6
-
28
-
-
77949267716
-
EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2
-
19838704 10.1007/s00259-009-1265-z 1:CAS:528:DC%2BC3cXhsVyisL0%3D
-
Van Laere K, Varrone A, Booij J, Vander Borght T, Nobili F, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:434-42.
-
(2010)
Eur J Nucl Med Mol Imaging
, vol.37
, pp. 434-442
-
-
Van Laere, K.1
Varrone, A.2
Booij, J.3
Vander Borght, T.4
Nobili, F.5
Kapucu, O.L.6
-
29
-
-
77949266557
-
EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2
-
19838702 10.1007/s00259-009-1267-x 1:CAS:528:DC%2BC3cXhsVyitr0%3D
-
Darcourt J, Booij J, Tatsch K, Varrone A, Vander Borght T, Kapucu OL, et al. EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:443-50.
-
(2010)
Eur J Nucl Med Mol Imaging
, vol.37
, pp. 443-450
-
-
Darcourt, J.1
Booij, J.2
Tatsch, K.3
Varrone, A.4
Vander Borght, T.5
Kapucu, O.L.6
-
30
-
-
26844541271
-
ACCF proposed method for evaluating the appropriateness of cardiovascular imaging
-
16226195 10.1016/j.jacc.2005.08.030
-
Patel MR, Spertus JA, Brindis RG, Hendel RC, Douglas PS, Peterson ED, et al. ACCF proposed method for evaluating the appropriateness of cardiovascular imaging. J Am Coll Cardiol. 2005;46:1606-13.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 1606-1613
-
-
Patel, M.R.1
Spertus, J.A.2
Brindis, R.G.3
Hendel, R.C.4
Douglas, P.S.5
Peterson, E.D.6
-
31
-
-
84875002679
-
SNMMI/EANM guideline for guideline development 6.0
-
22743147 10.2967/jnmt.112.108787
-
Delbeke D, Chiti A, Christian P, Darcourt J, Donohoe K, Flotats A, et al. SNMMI/EANM guideline for guideline development 6.0. J Nucl Med Technol. 2012;40:283-9.
-
(2012)
J Nucl Med Technol
, vol.40
, pp. 283-289
-
-
Delbeke, D.1
Chiti, A.2
Christian, P.3
Darcourt, J.4
Donohoe, K.5
Flotats, A.6
-
32
-
-
77957951112
-
Revising the definition of Alzheimer's disease: A new lexicon
-
20934914 10.1016/S1474-4422(10)70223-4
-
Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 2010;9:1118-27.
-
(2010)
Lancet Neurol
, vol.9
, pp. 1118-1127
-
-
Dubois, B.1
Feldman, H.H.2
Jacova, C.3
Cummings, J.L.4
Dekosky, S.T.5
Barberger-Gateau, P.6
-
34
-
-
84869116509
-
Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: A cross-sectional study
-
23137949 10.1016/S1474-4422(12)70227-2 1:CAS:528:DC%2BC38Xhs12gt7%2FO
-
Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gomez MG, Langois CM, et al. Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study. Lancet Neurol. 2012;11:1057-65.
-
(2012)
Lancet Neurol
, vol.11
, pp. 1057-1065
-
-
Fleisher, A.S.1
Chen, K.2
Quiroz, Y.T.3
Jakimovich, L.J.4
Gomez, M.G.5
Langois, C.M.6
-
35
-
-
79551495391
-
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
-
21280088 10.1002/ana.22248 1:CAS:528:DC%2BC3MXisVCisLs%3D
-
Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, et al. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Ann Neurol. 2011;69:181-92.
-
(2011)
Ann Neurol
, vol.69
, pp. 181-192
-
-
Villemagne, V.L.1
Pike, K.E.2
Chételat, G.3
Ellis, K.A.4
Mulligan, R.S.5
Bourgeat, P.6
-
36
-
-
84874238775
-
Impact of molecular imaging on the diagnostic process in a memory clinic
-
10.1016/j.jalz.2012.07.003 23164552
-
Ossenkoppele R, Prins ND, Pijnenburg YA, Lemstra AW, van der Flier WM, Adriaanse SF, et al., Impact of molecular imaging on the diagnostic process in a memory clinic. Alzheimers Dement. 2012. doi: 10.1016/j.jalz.2012.07.003.
-
(2012)
Alzheimers Dement
-
-
Ossenkoppele, R.1
Prins, N.D.2
Pijnenburg, Y.A.3
Lemstra, A.W.4
Van Der Flier, W.M.5
Adriaanse, S.F.6
-
37
-
-
84874241691
-
Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline
-
23203162 10.1097/WAD.0b013e318279d02a 1:CAS:528:DC%2BC3sXis12rsLk%3D
-
Grundman M, Pontecorvo MJ, Salloway SP, Doraiswamy PM, Fleisher AS, Sadowsky CH, et al. Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline. Alzheimer Dis Assoc Disord. 2013;27:4-15.
-
(2013)
Alzheimer Dis Assoc Disord
, vol.27
, pp. 4-15
-
-
Grundman, M.1
Pontecorvo, M.J.2
Salloway, S.P.3
Doraiswamy, P.M.4
Fleisher, A.S.5
Sadowsky, C.H.6
-
38
-
-
84874948210
-
Alzheimer disease: Aβ-independent processes-rethinking preclinical AD
-
10.1038/nrneurol.2013.21
-
Chételat G. Alzheimer disease: Aβ-independent processes-rethinking preclinical AD. Nat Rev Neurol. 2013. doi: 10.1038/nrneurol.2013.21.
-
(2013)
Nat Rev Neurol
-
-
Chételat, G.1
|